Tattoos May Be a Risk Factor for Lymphoma

[MEDPAGE TODAY]( Oncology Update Tuesday, May 28, 2024 [Tattoos May Be a Risk Factor for Lymphoma]( [Increase in CRC Cases in Younger Age Groups Extends to Preteens]( [A Life in Medical Innovation and Philanthropy]( [PERSPECTIVES]( [For Cancer Patients Facing Infertility, Access to IVF Is Paramount]( ADVERTISEMENT Exclusives & Features [Clues From Bird Flu's Ground Zero on Dairy Farms in the Texas Panhandle]( [Why preventive care is the cure for our failing health care system]( The future of health care necessitates a shift towards preventive measures, addressing systemic barriers in insurance coverage, and prioritizing early interventions to reduce the incidence of major... [READ MORE]( [Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.]( Methotrexate (MTX), although an indispensable part of contemporary treatment protocols for childhood acute lymphoblastic leukaemia (ALL)/lymphomas (LBL) in improving outcomes, can lead to serious... [READ MORE]( [Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model.]( BACKGROUND: For many tumors, radiomics provided a relevant prognostic contribution. This study tested whether the computed tomography (CT)-based textural features of intrahepatic cholangiocarcinoma... [READ MORE]( [Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL.]( BACKGROUND: There is a strong clinical need to fill the gap of identifying clinically significant prostate cancer (csPCa) in men with prostate-specific antigen (PSA) gray zone values. Promising, but... [READ MORE]( [Impact of comorbidities on prostate cancer-specific mortality: A population-based cohort study.]( AIM: To assess the impact of comorbidities on prostate cancer mortality.METHODS: We studied 15,695 South Australian men diagnosed with prostate cancer between 2003 and 2019 from state-wide... [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-05-28&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011